Colinz Laboratories has announced a board meeting held on 30th July, 2026, where the audited financial results for the quarter ended 30th June, 2026, and the year ended 31st March, 2026, were approved.

For the quarter, revenue from operations was 1.36 Cr, with a net profit of 2.40 Cr and EPS of 9.53 Rs. For the year, revenue was 6.62 Cr, with a net profit of 0.51 Cr and EPS of 2.04 Rs. During the quarter, the company received the final proceeds from its Sinnar factory sale, with manufacturing continuing on a third-party basis, indicating an asset-light operational shift.